Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, discusses how early data from ABBV-706 shows up to 50% ...

The incidence of neuroendocrine tumors is increasing, necessitating the need for more post-operative medical strategies. Available therapies and promising agents are discussed in this article.

Table 3. Proposal for tumor–node–metastasis classification and disease staging for endocrine tumors of the pancreas. Classification ...

Dong-A ST signed a joint sales agreement with Ibsen Korea on the 30th for the treatment of precocious puberty and prostate ...

Phase II, open-label, randomized study of first-line zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in Claudin 18.2–positive metastatic pancreatic cancer (mPC). Authors : Wungki Park , Eileen ...

Notably, pancreatic enzymes essential to digestion were altered by the high-fat diet but returned to normal levels or were further altered following antibiotic treatment. This alteration of pancreatic ...

Objective Recently, tumours with microsatellite instability (MSI)/defective DNA mismatch repair (dMMR) have gained considerable interest due to the success of immunotherapy in this molecular setting.